CLOD yields 1.86% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, CLOD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLOD + JNJ for your $10,000?
CLOD seeks to emulate the performance of the Solactive Cloud Computing Index, representing companies in cloud computing across developed markets. The index starts from a universe of small-, mid-, and large-cap companies that may be classified within defined sub-industries of the cloud computing industry. Security selection is based on the free float market capitalization of all eligible securities with firms ranking at the top of each sub-industry chosen. Twenty companies from internet infrastructure software and data support software, 10 each from digital security software, data infrastructure software, and data architecture software industries, and 3 from e-commerce infrastructure software are considered where the top 50 securities by market-cap are selected for the index. Constituents are also weighted according to their free float market capitalization with a 4.5% cap placed on individual securities. This is to ensure diversification and to limit overconcentration. CLOD is rebalanced quarterly.
Full CLOD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.